Luye Pharma Group Ltd. 2186 2016

02 03 05 06 14 18 19 20 21 23 24 26

中期報告 2016 02 公司概覽 30 3,400 300 10,000 1994 6 8 2004 2012 11 292014 7 9 21

03 綠葉製藥集團有限公司 公司資料 2016 6 8 2016 6 8 2016 6 8 Clarendon House 2 Church Street Hamilton HM 11 Bermuda 15 264003 1036 4-1 3 32 3207 Codan Services Limited Clarendon House 2 Church Street Hamilton HM 11 Bermuda

中期報告 2016 04 公司資料 ( 續 ) 183 17 1712 1716 1 22 1 11 Conyers Dill & Pearman 8 2901 2186 www.luye.cn

05 綠葉製藥集團有限公司 財務摘要 2015 6 3086.26.1%1,489.1 EBITDA 2015 6 3045.88.8%567.5 2015 6 30118.510.4%1,259.084.5% 2015 6 3039.110.2%424.6 12.782015 6 3011.61 2016 6 300.0320.037 2012 2013 2014 2015 2015 6 30 2016 6 30 1,713.8 1,996.5 2,544.0 2,563.1 1,402.8 1,489.1 1,362.0 1,583.0 2,061.5 2,087.4 1,140.4 1,259.0 EBITDA 368.2 508.2 875.9 1,028.9 521.8 567.5 175.6 327.9 614.4 764.7 394.1 423.1 169.0 310.5 605.5 754.5 385.4 424.6 2,677.6 3,387.5 6,130.8 7,052.9 6,944.0 9,263.3 1,093.8 1,489.8 1,093.2 1,253.4 1,519.6 3,037.3 1,583.8 1,897.7 5,037.6 5,799.5 5,424.4 6,226.0 15.93% 2.91% 16.86% 2.88% 56.32% 59.66% 24.84% 20.60%

中期報告 2016 06 管理層討論及分析 30 2016 6 30 2015 20166.1% IMS Health Incorporated IMS2016 IMS2016 IMS 2016IMS 2016IMS 2016IMS 2016 2016 201512.5% 12.3% 5.0%888.4 250.942.9 2016306.8 201512.0% IMS 20163182016 2016 51.9%2016 6 30

綠葉製藥集團有限公司 07 管理層討論及分析 ( 續 ) 2016 6 30 2009 2016 6 30 IMS2016 57IMS 2016 IMS 201611IMS 20162016 2016 68.0% 2016 6 30 IMS2016 16 2016 6.6%

中期報告 2016 08 管理層討論及分析 ( 續 ) 2016 6 3030040 1502016 6 30 25040 12050 IMS20132015 11.7%2016 6 30 2183 10 2016 3LY01005 LY01005 2016 8LY01005 2016 30 2016 601,3001,000 10,000 1,220 67.0% 2,950 43.0% 6,000 37.0%

綠葉製藥集團有限公司 09 管理層討論及分析 ( 續 ) 2016 2016 2016 3LY01005 LY01005 2016 8LY01005 2016 7 Acino AG Acino Supply AGTDS TDS 2016 6 301,489.12015 6 30 1,402.886.26.1% 2016 6 30 888.42015 6 30 790.098.412.5% 2016 6 30306.82015 6 30348.541.712.0%

中期報告 2016 10 管理層討論及分析 ( 續 ) 2016 6 30250.92015 6 30223.527.512.3% 2016 6 3042.92015 6 30 40.92.15.0% 2015 6 30262.4 2016 6 30 230.115.5% 2015 2016 6 30 2016 6 30 1,259.02015 6 30 1,140.4118.510.4% 2016 6 30201581.3% 84.5% 2016 6 30 78.92015 6 3059.019.9 2015 2016 6 30 2016 6 30 608.02015 6 30561.4 46.68.3% 2015 6 30 40.0%2016 6 30 40.8% 2016 6 30 119.92015 6 3083.736.2 43.3% 2016 6 30

綠葉製藥集團有限公司 11 管理層討論及分析 ( 續 ) 2016 6 30107.32015 6 3090.1 17.219.1% 2016 6 30 13.32015 6 30 7.65.776.0% 2016 6 30 2015 2016 6 3067.82015 6 30 63.0 4.87.5% 2016 6 30 2015 13.8% 2016 6 30423.12015 6 30 394.129.07.4% 2016 6 304,290.2 2015 12 31 4,026.0 2015 12 314.92016 6 30 2.5 2016 6 302,241.6 2015 12 31 502.7 2,241.1 0.5 2016 7 25Acino AG Acino Supply AG 16 2016 6 30 2015 12 318.7% 36.0%

中期報告 2016 12 管理層討論及分析 ( 續 ) 2016 6 30 2016 6 30 2016 6 303,431 2015 12 31 3,410 2016 6 30189.32015 172.2 2016 6 30 3,845 2014 6 26

綠葉製藥集團有限公司 13 管理層討論及分析 ( 續 ) 2016 8 29 2,000.452.0% % % 2016 8 29 % 769.0 20.0 150.0 3.9 619.0 16.1 769.0 20.0 250.0 6.5 519.0 13.5 769.0 20.0 150.0 3.9 619.0 16.1 769.0 20.0 681.4 17.7 87.6 2.3 192.2 5.0 192.2 5.0 192.2 5.0 192.2 5.0 384.6 10.0 384.6 10.0 3,845.0 2,000.4 1,844.6 2016 6 30 Acino AG Acino Supply AG 2016 7 25 Acino AG Acino Supply AG2016 7 25Luye Pharma (Germany) GmbH Luye Pharma Switzerland AG Acino International AG Acino Pharma AG Acino AG Acino Supply AG 245,000,000 Acino AG Acino Supply AG 2016 10 112016 6 30 0.0320.037 2015 6 30 106,300,000 2016 11 8

中期報告 2016 14 其他資料 14 2016 6 30 A.2.1 10 2016 6 30 2016 6 30 2016 6 30 2410 2016 6 30 13.51B(1) 2015 12 31 2016 5 18 8001

綠葉製藥集團有限公司 15 其他資料 ( 續 ) 13.51B(1) 2016 6 30 XV352 (1) (2) 1,517,113,930(L) 45.68% L (1) Shorea LBG Ginkgo Trust Limited Nelumbo Investments Limited 1,517,113,930 Nelumbo Investments Limited 70% (2) Nelumbo Inventments LimitedGinkgo Trust Limited Ginkgo Trust Limited Shorea LBGShorea LBG 8,400(L) 70% Ginkgo Trust Limited (1) 1(L) 100% Nelumbo Investments 1(L) 100% Limited (1) 1,136,852(L) 100% 202,180,988(L) 100% 1(L) 100% (2) 1,800(L) 15% (2) 1,800(L) 15% L

中期報告 2016 16 其他資料 ( 續 ) (1) Nelumbo Inventments LimitedGinkgo Trust Limited (2) 2016 6 30 XV352 2016 6 30 18 XV

綠葉製藥集團有限公司 17 其他資料 ( 續 ) 2016 6 30XV 336 (1) 1,517,113,930(L) 45.68% (1) 1,517,113,930(L) 45.68% (1) 1,517,113,930(L) 45.68% 1,517,113,930(L) 45.68% Nelumbo Investments Limited (2) 1,517,113,930(L) 45.68% Ginkgo Trust Limited (2) 1,517,113,930(L) 45.68% Shorea LBG (2) 1,517,113,930(L) 45.68% CPE Greenery Ltd. (3) 196,561,695(L) 5.92% CPEChina Fund, L.P. (3) 196,561,695(L) 5.92% CITIC PE Associates, L.P. (3) 196,561,695(L) 5.92% CITIC PE Funds Limited (3) 196,561,695(L) 5.92% CITICPE Holdings Limtied (3) 196,561,695(L) 5.92% (3) 196,561,695(L) 5.92% (3) 196,561,695(L) 5.92% (3) 196,561,695(L) 5.92% (4) 546,355,060(L) 16.45% (4) 546,355,060(L) 16.45% L (1) (2) Nelumbo Investments Limited 70% Nelumbo Investments Limited Ginkgo Trust Limited Ginkgo Trust Limited Shorea LBG (3) CPE Greenery Ltd. CPEChina Fund, L.P.CPEChina Fund, L.P.CITIC PE Associates, L.P. CITIC PE Associates, L.P.CITIC PE Funds Limited CITIC PE Funds Limited CITICPE Holdings Limited CITICPE Holdings Limited 35% (4) 49.56% 2016 6 30 XV23336

中期報告 2016 18 中期財務資料審閱報告 1 22 綠葉製藥集團 19 44 綠葉製藥集團 2016 6 30 34 34 34 2410 34 2016 8 29

19 綠葉製藥集團有限公司 中期簡明綜合損益表 6 30 2016 2015 4 1,489,075 1,402,848 (230,099) (262,421) 1,258,976 1,140,427 4 78,940 58,965 (608,037) (561,447) (119,937) (83,717) (107,275) (90,054) 6 (13,333) (7,577) 1,548 509 5 490,882 457,106 7 (67,791) (63,047) 423,091 394,059 424,569 385,437 (1,478) 8,622 423,091 394,059 9 12.78 11.61

中期報告 2016 20 中期簡明綜合全面收益表 6 30 2016 2015 423,091 394,059 (486) (1,678) 3,827 (1,024) 3,341 (2,702) 3,341 (2,702) 426,432 391,357 427,910 382,735 (1,478) 8,622 426,432 391,357

21 綠葉製藥集團有限公司 中期簡明綜合財務狀況表 2016 6 30 2015 12 31 10 1,265,588 1,196,262 66,034 48,762 209,918 185,813 347,356 347,356 119,320 126,216 5,809 4,350 11 3,550 3,342 92,005 69,377 2,109,580 1,981,478 330,203 285,609 12 1,504,748 1,193,103 13 510,986 118,249 18(b)(i) 1,172 1,600 11 616,349 1,402,118 14 885,618 266,500 14 145,000 960,591 14 3,159,646 843,674 7,153,722 5,071,444 15 93,610 83,219 386,281 366,457 16 2,241,102 502,222 67,536 25,155 73,114 64,946 18(b)(ii) 1,850 3,428 2,863,493 1,045,427 4,290,229 4,026,017 6,399,809 6,007,495

中期報告 2016 22 中期簡明綜合財務狀況表 ( 續 ) 2016 6 30 2015 12 31 6,399,809 6,007,495 16 455 493 77,591 115,150 95,800 92,321 173,846 207,964 6,225,963 5,799,531 427,269 427,269 2,936,817 2,936,817 2,727,785 2,299,875 6,091,871 5,663,961 134,092 135,570 6,225,963 5,799,531

23 綠葉製藥集團有限公司 中期簡明綜合權益變動表 2016 6 30 * * * * * 2016 1 1 427,269 2,936,817 41,387 328,184 1,930,906 2,042 (2,644) 5,663,961 135,570 5,799,531 424,569 424,569 (1,478) 423,091 (486) (486) (486) 3,827 3,827 3,827 424,569 (486) 3,827 427,910 (1,478) 426,432 2016 6 30 427,269 2,936,817 41,387 328,184 2,355,475 1,556 1,183 6,091,871 134,092 6,225,963 2015 6 30 2015 1 1 427,269 2,936,817 41,387 297,796 1,206,771 4,253 (6,695) 4,907,598 129,962 5,037,560 385,437 385,437 8,622 394,059 (1,678) (1,678) (1,678) (1,024) (1,024) (1,024) 385,437 (1,678) (1,024) 382,735 8,622 391,357 (4,567) (4,567) 2015 6 30 427,269 2,936,817 41,387 297,796 1,592,208 2,575 (7,719) 5,290,333 134,017 5,424,350 * 2016 6 30 2,727,785,000

中期報告 2016 24 中期簡明綜合現金流量表 6 30 2016 2015 490,882 457,106 (1,548) (509) 63,332 57,075 5 430 149 4 (18,387) (6,224) 4 (26,774) (36,577) 6 13,333 7,577 521,268 478,597 (311,645) (480,467) 12,933 (7,845) 428 (2,430) (44,594) 27,832 (18,512) (8,011) 3,622 7,018 10,391 (2,682) (10,764) 120,926 (1,578) 161,549 132,938 (9,327) (6,602) (78,605) (47,602) 73,617 78,734

25 綠葉製藥集團有限公司 中期簡明綜合現金流量表 ( 續 ) 6 30 2016 2015 73,617 78,734 (141,435) (83,535) (2,111,000) (1,395,000) 2,896,002 1,840,465 17,404 36,577 448 262 700,000 1,200 (4,522) 815,591 (360,000) (392,106) (600,000) 200,000 682 22,087 2,842 708,873 737,089 (826,238) (847,229) 2,565,080 1,145,227 (208,500) (187,400) 1,530,342 110,598 2,312,832 926,421 3,140 (864) 1 1 843,674 151,863 6 30 3,159,646 1,077,420

中期報告 2016 26 中期簡明綜合財務報表附註 1. 綠葉製藥集團 2016 6 30 2016 8 29 2003 7 22004 5 5 2012 11 29 2014 7 9 Clarendon House, 2 Church Street, Hamilton HM 11, Bermuda 33207 2. 2.1 2016 6 30 34 2015 12 31 2.2 2015 6 30 347,868,000 2015 6 30

27 綠葉製藥集團有限公司 中期簡明綜合財務報表附註 ( 續 ) 2. 2.3 2015 12 31 2016 1 1 10 12 28 11 14 1 16 38 16 41 27 20122014 3.

中期報告 2016 28 中期簡明綜合財務報表附註 ( 續 ) 3. 2016 6 30 888,430 306,804 250,923 42,918 1,489,075 888,430 306,804 250,923 42,918 1,489,075 435,139 115,699 91,605 8,496 650,939 78,940 (119,937) (107,275) (13,333) 1,548 490,882 2015 6 30 790,038 348,491 223,454 40,865 1,402,848 790,038 348,491 223,454 40,865 1,402,848 363,854 123,234 87,594 4,298 578,980 58,965 (83,717) (90,054) (7,577) 509 457,106

29 綠葉製藥集團有限公司 中期簡明綜合財務報表附註 ( 續 ) 4. 6 30 2016 2015 1,522,826 1,436,003 (33,751) (33,155) 1,489,075 1,402,848 18,387 6,224 32,501 15,002 26,774 36,577 1,278 1,162 78,940 58,965 5. 6 30 2016 2015 49,017 42,469 11,680 11,970 2,635 2,636 9,619 6,541 1,680 1,680 83,981 86,035 230,099 262,421 21,944 2,457 430 149

中期報告 2016 30 中期簡明綜合財務報表附註 ( 續 ) 6. 6 30 2016 2015 13,317 7,562 16 15 13,333 7,577 7. 6 30 2016 2015 86,691 66,812 82 (1,432) (18,982) (2,333) 67,791 63,047 8. 2016 8 292016 6 300.032 2015 6 30

31 綠葉製藥集團有限公司 中期簡明綜合財務報表附註 ( 續 ) 9. 3,321,073,843 2015 6 30 3,321,073,843 6 30 2016 2015 424,569 385,437 6 30 2016 2015 3,321,073,843 3,321,073,843 20162015 6 30 10. 2016 6 30 2015 12 31 1,196,262 1,092,151 119,221 191,341 (49,017) (86,280) (878) (950) 1,265,588 1,196,262 2016 6 301,486,000 2015 12 311,519,000

中期報告 2016 32 中期簡明綜合財務報表附註 ( 續 ) 11. 2016 6 30 2015 12 31 616,349 1,402,118 3,050 2,842 500 500 3,550 3,342 2.45% 3.30% (a)(b) 2016 6 30600,000,000 2015 12 31

33 綠葉製藥集團有限公司 中期簡明綜合財務報表附註 ( 續 ) 12. 2016 6 30 2015 12 31 755,478 622,554 751,518 572,673 1,506,996 1,195,227 (2,248) (2,124) 1,504,748 1,193,103 2016 6 30 2015 12 31 609,937 530,615 85,101 50,876 56,233 37,347 2,879 2,145 1,328 1,571 755,478 622,554 2016 6 302015 12 31 15,805,000 10,235,000 15 2016 6 30 70,556,000 2015 12 3173,157,000 810,713,000 2015 12 312016 6 30

中期報告 2016 34 中期簡明綜合財務報表附註 ( 續 ) 12. 2016 6 30 29,916,000 2015 12 3144,662,000 2016 6 30 40,640,000 2015 12 3128,495,000 810,713,000 2015 12 31 13. 2016 6 30 2015 12 31 400,000 89,013 80,427 3,904 3,904 21,069 36,918 513,986 121,249 (3,000) (3,000) 510,986 118,249 0.52016 7 2016 6 30 2015 12 31 510,986 118,249

35 綠葉製藥集團有限公司 中期簡明綜合財務報表附註 ( 續 ) 14. 2016 6 30 2015 12 31 3,159,646 843,674 1,030,618 1,227,091 4,190,264 2,070,765 (33,109) (475,000) (266,500) * (377,509) (145,000) (960,591) 3,159,646 843,674 619,456 561,697 2,533,712 267,366 6,478 14,611 3,159,646 843,674 * 2016 6 30 13,887,000 2015 12 31 363,622,000 2015 12 31 15

中期報告 2016 36 中期簡明綜合財務報表附註 ( 續 ) 15. 2016 6 30 2015 12 31 72,723 72,984 20,887 10,235 93,610 83,219 2016 6 30 2015 12 31 87,497 71,221 2,655 9,751 2,008 1,420 1,132 513 318 314 93,610 83,219 90 2016 6 3020,887,000 2015 12 31 13,887,000 2015 12 3114 2015 12 3110,235,00015,805,000 12

37 綠葉製藥集團有限公司 中期簡明綜合財務報表附註 ( 續 ) 16. 2016 6 30 (%) 80,000,000 3.61 2016 9 12 80,000 22,300,000 3.61 2016 9 20 22,300 4,850,000 3.61 2016 9 20 4,850 160,000,000 3.70 2016 7 25 160,000 70,000,000 3.70 2016 8 27 70,000 330,000,000 3.70 2016 8 27 330,000 85,000,000 3.70 2016 8 29 85,000 25,000,000 +1.65 2017 4 1 165,780 40,000,000 +0.75 2016 7 28 265,248 33,500,000 +0.8 2017 4 1 247,063 3.40 2016 8 23 10,713 3.70 2016 10 25 200,000 3.07 2016 12 24 600,000 2.2 2017 6 30 148 2,241,102 2.2 2017 7 1 2020 8 30 455 2,241,557

中期報告 2016 38 中期簡明綜合財務報表附註 ( 續 ) 16. 2015 12 31 (%) 80,000,000 3.77 2016 3 15 80,000 25,000,000 +1.8 2016 4 1 162,340 40,000,000 +0.75 2016 7 28 259,744 2.2 2016 12 31 138 502,222 2.2 2017 1 1 2020 8 30 493 502,715 475,500,000 2015 12 31 266,500,000 14 17. 2016 6 30 2015 12 31 86,682 75,467 147,739 106,215 234,421 181,682

39 綠葉製藥集團有限公司 中期簡明綜合財務報表附註 ( 續 ) 18. Steward Cross Pte. Ltd. Steward Cross (a) 20162015 6 30 6 30 2016 2015 Steward Cross (i) 3,844 3,609 (ii) 1,439 2,873 (i) Steward Cross (ii)

中期報告 2016 40 中期簡明綜合財務報表附註 ( 續 ) 18. (b) 2016 6 302015 12 31 (i) 2016 6 30 2015 12 31 Steward Cross 1,172 1,600 (ii) 2016 6 30 2015 12 31 1,850 3,428 19. 2016 6 302015 12 31 2016 6 30 619,899 619,899 1,504,748 1,504,748 489,013 489,013 3,159,646 3,159,646 145,000 145,000 885,618 885,618 1,172 1,172 6,185,197 619,899 6,805,096

41 綠葉製藥集團有限公司 中期簡明綜合財務報表附註 ( 續 ) 19. 2016 6 302015 12 31 2016 6 30 93,610 93,610 205,425 205,425 2,241,557 2,241,557 2,540,592 2,540,592 2015 12 31 1,405,460 1,405,460 1,193,103 1,193,103 80,427 80,427 843,674 843,674 960,591 960,591 266,500 266,500 1,600 1,600 3,345,895 1,405,460 4,751,355

中期報告 2016 42 中期簡明綜合財務報表附註 ( 續 ) 19. 2016 6 302015 12 31 2015 12 31 83,219 83,219 194,336 194,336 502,715 502,715 780,270 780,270 39 11

43 綠葉製藥集團有限公司 中期簡明綜合財務報表附註 ( 續 ) 20. 2016 6 30 3,050 3,050 616,349 616,349 3,050 616,349 619,399 2015 12 31 2,842 2,842 1,402,118 1,402,118 2,842 1,402,118 1,404,960 2015 6 30 2016 6 302015 12 31

中期報告 2016 44 中期簡明綜合財務報表附註 ( 續 ) 21. 2016 7 25 Luye Pharma (Germany) GmbH Luye Pharma Switzerland AG Acino International AG Acino Pharma AG Acino AG Acino Supply AG 245,000,000 Acino AG Acino Supply AG 2016 7 25